Differential effects of a murine monoclonal antibody reactive with the disialylgalactosyl residue on the growth of melanoma cells and T cell activation: Comparison with anti-GD3 antibody R24

International Journal of Oncology

Volumn 9, Issue 2, 1996, Pages 241-245

  Miyazaki, Hiroshi ^a   Shiku, Hiroshi ^b   Furukawa, Koichi ^a  

^a NAGASAKI UNIVERSITY   (Japan)

^b MIE UNIVERSITY   (Japan)

Author keywords

Disialylgalactose; Ganglioside; GD3; Monoclonal antibody

Indexed keywords

GANGLIOSIDE GD3; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY R24; MONOCLONAL ANTIBODY S2 566; UNCLASSIFIED DRUG;

ANTIGEN RECOGNITION; ARTICLE; CANCER CELL CULTURE; CANCER IMMUNIZATION; CANCER IMMUNOLOGY; CANCER INHIBITION; CONTROLLED STUDY; HUMAN; HUMAN CELL; MELANOMA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

EID: 0030038298     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Hakomori S: Bifunctional role of glycosphingolipids. Modulators for transmembrane signaling and mediators for cellular interactions. J Biol Chem 265: 18713-18716, 1990.
2. Wiegandt H: Gangliosides. In: Glycolipids. Wiegandt H (ed). Elsevier, New York, pp199-260, 1985.
3. Pukel CS, Lloyd KO, Travassos LR, Dippold WG, Oetggen HF and Old LJ: GD3, a prominent ganglioside of human melanoma. Detection and characterization by mouse monoclonal antibody. J Exp Med 155: 1133-1147, 1982.
4. Cheung NV, Sarrinen UM, Neely JE, Landmeier B, Donovan D and Coccia PF: Monoclonal antibodies to a glycolipid antigen on human neuroblastoma cells. Cancer Res 45: 2642-2649, 1985.
5. Furukawa K and Lloyd KO: Gangliosides in melanoma. In: Human Melanoma. From Basic Research to Clinical Application. Ferrone S (ed). Springer-Verlag, Heidelberg, pp15-30, 1990.
6. Kawashima I, Tada N, Ikegami S, Nakamura S, Ueda R and Tai T: Mouse monoclonal antibodies detecting disialogangliosides on mouse and human lymphomas. Int J Cancer 41: 267-274, 1990.
7. Yamaguchi H, Furukawa K, Fortunato SR, Livingston PO, Lloyd KO, Oettgen HF and Old LJ: Human monoclonal antibody with dual GM2/GD2 specificity derived from an immunized melanoma patient. Proc Natl Acad Sci USA 87: 3333-3337, 1990.
8. Thurin J, Thurin M, Kimoto Y, Herlyn M, Lubeck M, Elder D, Smereczynska M, Karlsson K, Clark W, Steplewski Z and Koprowski H: Monoclonal antibody-defined correlations in melanoma between levels of GD2 and GD3 antigens and antibody-mediated cytotoxicity. Cancer Res 47: 1229-1233, 1987.
9. Yoshida K, Hamatani K, Koide H, Ikeda H, Nakamura N, Akiyama M, Tsuchiyama H, Nakayama E and Shiku H: Preparation of anti-ras Mr 21,000 protein monoclonal antibodies and immunohistochemical analyses on expression of ras genes in human stomach and thyroid cancers. Cancer Res 48: 5503-5509, 1988.
10. Shiku H, Takahashi T, Oettgen HF and Old LJ: Cell surface antigens of human malignant melanoma. II Serological typing with immuneadherence assays and definition of two new surface antigens. J Exp Med 144: 873-881, 1976.
11. Real FX, Mattes MJ, Houghton AN, Oettgen HF, Lloyd KO and Old LJ: Class 1 (unique) tumor antigens of human melanoma. Identification of a 90,000 dalton cell surface glycoproteins by autologous antibody. J Exp Med 160: 1219-1233, 1984.
12. Furukawa K, Clausen H, Hakomori S, Sakamoto J, Look K, Lundblad A, Mattes MJ and Lloyd KO: Analysis of the specificity of five murine anti-blood group A monoclonal antibodies, including one that identifies type 3 and type 4 determinants. Biochemistry 24: 7820-7826, 1985.
13. Yamashiro S, Urano T, Shiku H and Furukawa K: Alteration of nm23 gene expression during the induced differentiation of human leukemia cell lines. Oncogene 9: 2461-2468, 1994.
14. 252Cf fission fragment ionization mass spectrometry in the analysis of glycosphingolipids. J Biol Chem 263: 14939-14947, 1988.
15. Furukawa K, Yamaguchi H, Oettgen HF, Old LJ and Lloyd KO: Analysis of the expression of N-glycolylneuraminic acid-containing gangliosides in cells and tissues using two human monoclonal antibodies. J Biol Chem 263: 18501-18512, 1988.
16. Tai T, Kawashima I, Furukawa K and Lloyd KO: Monoclonal antibody R24 distinguishes between different N-acetyl and N-glycolyl neuraminic acid derivatives of ganglioside GD3. Arch Biochem Biophys 260: 51-55, 1988.
17. Furukawa K, Yamaguchi H, Oettgen HF, Old LJ and Lloyd KO: Two human monoclonal antibodies reacting with the major gangliosides of human melanoma and comparison with corresponding mouse monoclonal antibodies. Cancer Res 49: 191-196, 1989.
18. Watarai S, Onuma N and Yasuda T: Production of monoclonal antibodies specific for ganglioside GD3. J Biochem 110: 889-895, 1991.
19. Dippold WG, Knuth A and Meyer zum Buschenfelde KH: Inhibition of human melanoma cell growth in vitro by monoclonal anti-GD3-ganglioside antibody. Cancer Res 44: 806-810, 1984.
20. Welte K, Miller G, Chapman PB, Yuasa H, Natoli E, Kunicka JE, Cordon-Cardo C, Buhrer C, Old LJ and Houghton AN: Stimulation of T lymphocyte proliferation by monoclonal antibodies against GD3 ganglioside. J Immunol 139: 1763-1771, 1987.
21. Svennerholm: Chromatographic separation of human brain gangliosides. J Neurochem 10: 613-623, 1963.